In an era of persistent inflation and volatile markets, I find myself asking an important question for biotech companies looking to preserve and optimize the capital they have: Could allocating a portion of treasury cash to Bitcoin help preserve, optimize, and even extend a company’s runway and hence contribute to its success?
Huge kudos for paving the way as the first (public) psychedelic company to adopt a BTC treasury! I recently came to the similar conclusion that it will be imperative for ALL psychedelic companies to do so not only to hedge against inflation, but also extend its runway amidst regulatory hurdles with unknown timelines and to not cut corners as psychedelics gets commercially integrated into above-ground mainstream.
P.S. recently finished creating a level 1 presentation titled "Bitcoin: The Ultimate Ego Test (A Psychedelic Journey Through the Matrix of Money) and currently in the beginning stages of creating a level 2 presentation titled "The Sacred Parallels of Psychedelics x Bitcoin (Freedom Within, Freedom Without). Looking forward to your part 2!
Huge kudos for paving the way as the first (public) psychedelic company to adopt a BTC treasury! I recently came to the similar conclusion that it will be imperative for ALL psychedelic companies to do so not only to hedge against inflation, but also extend its runway amidst regulatory hurdles with unknown timelines and to not cut corners as psychedelics gets commercially integrated into above-ground mainstream.
P.S. recently finished creating a level 1 presentation titled "Bitcoin: The Ultimate Ego Test (A Psychedelic Journey Through the Matrix of Money) and currently in the beginning stages of creating a level 2 presentation titled "The Sacred Parallels of Psychedelics x Bitcoin (Freedom Within, Freedom Without). Looking forward to your part 2!